The six companies involved were Mead Johnson and Abbot from the U.S., Biostime, which is listed in Hong Kong, Dumex, a subsidiary of France’s Danone, Friesland from the Netherlands and New Zealand giant Fonterra.
Mead Johnson said it had been handed a penalty of 204 million yuan.
Biostime said it had been given a 163 million yuan fine.
Fonterra was fined 4.5 million yuan.
“The investigation leaves us with a much clearer understanding of expectations around implementing pricing policies which is useful as we progress our future business plans,” Fonterra’s president for Greater China and India, Kelvin Wickham, said in a statement.
According to Xinhua news agency, three companies – Wyeth, which is owned by Swiss giant Nestle, Japan’s Meiji, and Chinese firm Beingmate – had been exempted from punishment.
The fines, announced by China’s National Development and Reform Commission, coincide with a separate pricing investigation into the pharmaceutical industry.
Image: © Getty
Copyright is owned by Asia Outlook and/or Outlook Publishing. All rights reserved.